General Information of Drug (ID: DM6EICU)

Drug Name
N-[O-Phosphono-Pyridoxyl]-Isoleucine Drug Info
Synonyms ILP; AC1L9K3U; (3S)-2-[[3-hydroxy-2-methyl-5-(phosphonooxymethyl)pyridin-4-yl]methylamino]-3-methylpentanoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
46936443
TTD Drug ID
DM6EICU

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pyridoxamine-5'-Phosphate DMQ6POC Discovery agent N.A. Investigative [1]
Alpha-ketoisovalerate DMBZTS5 Discovery agent N.A. Investigative [1]
N'-(phenylsulfonyl)benzofuran-2-carbohydrazide DMJO3B1 Discovery agent N.A. Investigative [2]
N'-(phenylsulfonyl)quinoline-6-carbohydrazide DMQETUY Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Branched-chain-amino-acid transaminase 2 (BCAT2) TTF9OQ6 BCAT2_HUMAN Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16(9):2337-40.